Bedrock, DDB Remedy and Insypher lead the agency field, Gilead tops the pharma chart - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/2018_pm_society_digital_awards_winners_announced_1252993Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021We asked the winning companies from the 2017 Communications Team of the Year competition what pharma’s comms priorities should be - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/janfeb/loud_and_clearLondon-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334- Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/june_2018/together_as_oneIf approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852New hires from Bisector 2 and Tonic - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/90ten_boosts_pr_division_1022156Merger mania slowed but certainly didn't disappear in 2016 - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2016/december/review_of_the_year_2016_m_and_aCopycat of blockbuster breast cancer drug is Pfizer's first oncology biosimilar - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/ema_approves_pfizers_herceptin_biosimilar_1246372
